BCHE and Alzheimer disease: Due to the multi-factorial causes, the advancement of novel molecules is aimed at multi-targeting therapy such as cholinesterase inhibition, anti-amyloid effects, β-secretase and MAO blockage, nitric oxide delivering ability and interactivity with cannabinoid, and NMDA or histamine receptors, contributing to an effective approach in AD.